Metro International Biotech (MIB626)
Company
A company with phase 2 and 3 trials for Alzheimer's using a stabilized form of NAD+ (MIB626) and other NAD+ molecules.
Mentioned in 1 video
A company with phase 2 and 3 trials for Alzheimer's using a stabilized form of NAD+ (MIB626) and other NAD+ molecules.